PRESS RELEASE
SVAS BIOSANA PUBLISHES
ITS FINANCIAL CALENDAR FOR 2022
Somma Vesuviana (Naples) 28 January 2022 - Svas Biosana S.p.A., (the "Company" or "SVAS"), a leading player in the production and distribution of medical devices for public and private healthcare facilities, and listed on Euronext Growth Milan, a multilateral trading system organised and managed by Borsa Italiana S.p.A. which focuses on small and medium-sized companies with high growth potential, publishes its financial calendar for 2022 in accordance with the disclosure requirements set out in article 17 of Euronext Growth Milan's Issuer Regulation. The calendar was approved by the Board of directors.
DATE | EVENT |
14 April 2022 | Meeting of the Board of directors to approve the draft |
financial statements as at and for the year ended 31 | |
December 2021 | |
16 May 2022 | Ordinary Shareholders' Meeting to approve the financial |
statements as at and for the year ended 31 December 2021 | |
26 September 2022 | Meeting of the Board of directors to approve the interim |
financial report as at and for the six months ending 30 June | |
2022, subject to review by the independent auditors | |
The above dates may be subject to change, always in compliance with the terms provided for by applicable laws and regulations. Should this be the case, Svas Biosana S.p.A. will promptly inform the market.
* * * * * *
The financial calendar is available on the Company's website at the following address: https://svas.it/investor-relations/calendario-finanziario/.
This press release can be found at Borsa Italiana, at the Company's registered office, and in the Investor Relations/Financial Press Releases section of the website www.svas.it. Svas Biosana uses the eMarket SDIR system, managed by Spafid Connect S.p.A., with registered office at Foro Buonaparte 10, Milan (www.emarketstorage.com), to disclose regulated information.
* * * * * * * *
SVAS BIOSANA S.p.A. | Registered Office | Correspondence | Headquarters and Offices | Contacts |
Companies Register of | Via M. Perillo, 34 | Post Box 91 | Via Trentola, 7 | Tel. +390818995411 |
Naples no. 4543/85 | 80047 | 80049 | 80049 | Fax +390818993922 |
R.E.A. no. 393065 | San Giuseppe Vesuviano (NA) | Somma Vesuviana (NA) | Somma Vesuviana (NA) | www.svas.it |
Tax Code 04720630633 | Italy | Italy | Italy | svasbiosana@legalmail.it |
VAT no. 01354901215 |
Contacts:
SVAS Biosana S.p.A. | Euronext Growth Advisor |
Andrea Efficace | Banca Profilo |
CFO Group and Investor Relations Manager | Via Cerva 128, Milan |
+39 081.8995411 | +39 02.584081 |
alessio muretti@bancaprofilo.it |
Investor Relations Advisor | Media Relations Advisor |
POLYTEMS HIR | POLYTEMS HIR |
Bianca FERSINI MASTELLONI - Silvia MARONGIU | Paolo SANTAGOSTINO |
+06.69923324-066797849 | +393493856585 |
Specialist | |
Banca Profilo | |
+39 02.584081 |
Svas Biosana manufactures and distributes medical devices in Italy and abroad. Founded in 1972 in Somma Vesuviana (NA) by the Perillo family, SVAS is now an international company with a catalogue of approximately 16,000 own and third-party brand products, roughly 370 employees, a Research and Development department, 3 production facilities in Italy and subsidiaries in Slovenia, Croatia, Serbia and Bosnia- Herzegovina.
Ticker: ISIN Ordinary Shares: IT0005469264 Ticker: ISIN Warrant SVAS BIOSANA 2021-2024: IT0005469157
SVAS BIOSANA S.p.A. | Registered Office | Correspondence | Headquarters and Offices | Contacts |
Companies Register of | Via M. Perillo, 34 | Post Box 91 | Via Trentola, 7 | Tel. +390818995411 |
Naples no. 4543/85 | 80047 | 80049 | 80049 | Fax +390818993922 |
R.E.A. no. 393065 | San Giuseppe Vesuviano (NA) | Somma Vesuviana (NA) | Somma Vesuviana (NA) | www.svas.it |
Tax Code 04720630633 | Italy | Italy | Italy | svasbiosana@legalmail.it |
VAT no. 01354901215 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Svas Biosana S.p.A. published this content on 28 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 January 2022 16:52:07 UTC.